Toll Free: 1-888-928-9744

Hyperkalemia Global Clinical Trials Review, H1, 2016

Published: May 31, 2016 | Pages: 51 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Hyperkalemia Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Hyperkalemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperkalemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperkalemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Countries Contributing to Clinical Trials in Middle East and Africa 12 Clinical Trials by G7 Countries: Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials 13 Clinical Trials by Phase in G7 Countries 14 Clinical Trials in G7 Countries by Trial Status 15 Clinical Trials by E7 Countries: Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials 16 Clinical Trials by Phase in E7 Countries 17 Clinical Trials in E7 Countries by Trial Status 18 Clinical Trials by Phase 19 In Progress Trials by Phase 20 Clinical Trials by Trial Status 21 Clinical Trials by End Point Status 22 Subjects Recruited Over a Period of Time 23 Clinical Trials by Sponsor Type 24 Prominent Sponsors 25 Top Companies Participating in Hyperkalemia Therapeutics Clinical Trials 26 Prominent Drugs 27 Latest Clinical Trials News on Hyperkalemia 28 May 22, 2016: Data from New Analyses of Studies with Veltassa Presented at 53rd European Renal Association Congress 28 Apr 28, 2016: Data from New Analyses of Studies with Veltassa Presented at National Kidney Foundation 2016 Spring Clinical Meetings 28 Apr 21, 2016: Relypsa Announces Upcoming Veltassa Data Presentations at National Kidney Foundation 2016 Spring Clinical Meetings 29 Clinical Trial Profile Snapshots 31 Appendix 48 Abbreviations 48 Definitions 48 Research Methodology 49 Secondary Research 49 About GlobalData 50 Contact Us 50 Disclaimer 50 Source 51
List of Tables
Hyperkalemia Therapeutics, Global, Clinical Trials by Region, 2016* 6 Hyperkalemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Hyperkalemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Hyperkalemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 9 Hyperkalemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 Hyperkalemia Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 Hyperkalemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12 Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016* 13 Hyperkalemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14 Hyperkalemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15 Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016* 16 Hyperkalemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17 Hyperkalemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18 Hyperkalemia Therapeutics, Global, Clinical Trials by Phase, 2016* 19 Hyperkalemia Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20 Hyperkalemia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21 Hyperkalemia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22 Hyperkalemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23 Hyperkalemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24 Hyperkalemia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25 Hyperkalemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26 Hyperkalemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27


List of Figures
Hyperkalemia Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Hyperkalemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Hyperkalemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Hyperkalemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 9 Hyperkalemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 Hyperkalemia Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 Hyperkalemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12 Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016* 13 Hyperkalemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14 Hyperkalemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15 Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016* 16 Hyperkalemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17 Hyperkalemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18 Hyperkalemia Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19 Hyperkalemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20 Hyperkalemia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21 Hyperkalemia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22 Hyperkalemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23 Hyperkalemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24 Hyperkalemia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25 Hyperkalemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26 Hyperkalemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27 GlobalData Methodology 49

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

North America air conditioner market size is expected to be valued at USD 52,560.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing usage of energy efficient air conditioners owing to declining energy consumption rat

Read More...

Global advanced energy storage systems market size is anticipated to be valued at USD 24.8 billion by 2022, as per a new research report by Radiant Insights, Inc. Increasing energy consumption coupled with strong energy demand for industrial, commerc

Read More...

Global Aerial Work Platform (AWP) truck market is expected to be valued at USD 8,003.7 million by 2022, as per a new research report by Radiant Insights, Inc. Rapid infrastructure growth due to rising real estate investment is expected to drive the i

Read More...

Global heat transfer fluids market size is likely to be valued at USD 3.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing demand for for heat recovery management in industries such as metal processing, pharmaceutica

Read More...

Global automotive relay market is anticipated to reach USD 12 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising need for high-frequency signals in automotive industry is expected to drive demand. These relays enhance driv

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify